The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumResearch - BioSante Pharmaceuticals (NASDAQ:BPAX) is giving up gains from Tuesday’s momentary spike and is down 22%, from $1.66 to $1.35. The company reported completion of a … Continue Reading
Read now- After publishing an update on on the company’s lead product, H.P. Acthar Gel, shares of Questcor Pharmaceuticals (NASDAQ:QCOR) were up 6% in early trading on … Continue Reading
Read nowShort Ideas - Shares of Elan (NYSE:ELN) have been buoyed by two hopeful catalytic events, both of which appear to have gone away. As a result, this stock, … Continue Reading
Read nowLong Ideas - The Cooper Companies (NYSE:COO) handily beat estimates when it reported fiscal 3Q 2012 (F3Q) results Thursday night. Total sales for F3Q came in at $378M, … Continue Reading
Read nowQuick Picks - ImmunoCellular Therapeutics (NYSEAMEX:IMUC) is showing big gains on Thursday after the Maxim Group initiated coverage of the company with a Buy rating and a price … Continue Reading
Read nowLong Ideas - Orexigen Therapeutics (NASDAQ:OREX) continues this week’s gains in early trading on Thursday, up roughly 20% to $5.35 since Tuesday. The strength comes from Orexigen’s announcement … Continue Reading
Read nowLong Ideas - After announcing Wednesday morning that it has completed enrollment of its latest Phase 3 Pimavanserin trial, dubbed the -020 study, Acadia Pharmaceuticals (NASDAQ:ACAD) gained 4% … Continue Reading
Read now
